When Paul Wood first described primary pulmonary hypertensionl 2 he believed it to have a vasoconstrictive origin and showed that the pulmonary vascular resistance could be selectively lowered in some but not all of these patients by infusion of acetyl choline into the pulmonary artery3 in contrast to patients with the Eisenmenger syndrome, who were invariably unresponsive.34 The pathogenesis has since been argued, microthromboembolism and thrombosis in situ having some proponents, but the concept of an increased smooth muscle tone perhaps generated by endothelial damage and platelet activity has gained ground. Efforts to find an effective orally active specific pulmonary arteriolar dilator have continued over the years but with little success, though there has been considerable recent resurgence of interest.
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Observations made in beef cattle grazing at high altitude and in humans living and exercising at altitude have shown an individual and species variability suggesting a genetically determined hyperreactivity.5 This pulmonary hypertension is reversible on return to sea level, and the incidence of primary pulmonary hypertension is seemingly higher in populations living at high altitudes.6 Childhood7 and familial cases are weli known,8 and an association with Raynaud's phenomenon was early noted. 9 In the European epidemic of primary pulmonary hypertension, which was linked with the slimming drug aminorex fumarate, only an estimated 0-2% of individuals taking the drug developed the disease and the condition was usually reversible.'0 Primary pulmonary hypertension has also been linked with fenfluramine,II an anorectic which is still available. A concept of idiosyncratic pulmonary hypertension of possible dietary origin grew from this experience and from observations of a malignant type of pulmonary hypertension in rats who had eaten seeds ofCrotalaria spectabilis which contains the alkaloid monocrotaline. ' Oakley become hypotensive or to die suddenly. In such patients a favourable response to a drug may be seen by an increase in systemic arterial oxygen content while a fall signals selective systemic vasodilatation with an increase in right to left shunting. Unlike in mitral stenosis successful reduction in pulmonary vascular resistance in primary pulmonary hypertension is not normally associated with a fall in systemic arterial saturation, caused by perfusion of underventilated lung, provided the cardiac outpu rics.2 Recruitment of previously unperfused vessels rather than a general relaxation of vasomotor tone may possibly account for some observed rises in cardiac output associated with a fall in both systemic and pulmonary artery pressures. This phenomenon may explain refractory hypotension and death reported with incremental dosage of a drug which had seemed to be well tolerated27 or there may be rapid attenuation of an initially favourable response. 32 In some patients given a vasodilating inotropic agent such as isoprenaline the pulmonary artery pressure has fallen33 34; in others it has caused a rise in right ventricular output with a deleterious rise in pulmonary artery pressure35 associated with failure to dilate the lung vessels; calculated resistance may stay the same or actually fall, tachycardia is usual, and tremor uncomfortable.
Confficting responses (many favourable but some adverse) have been reported from acute studies of many different vasodilators either infused into the pulmonary artery or given intravenously: acetyl choline,4 tolazoline,36 phentolamine,37-39 isoprenaline,33 34 Patients with systemic lupus erythematosus who are found to have the lupus anticoagulant should be early suspects for pulmonary hypertension; it is of interest that nifedipine is the usual drug of choice for the treatment of Raynaud's phenomenon and might be preventing the development or progression of associated pulmonary hypertension in some of these patients. Heart"and lung transplantation is the final radical treatment for pulmonary vascular disease in primary pulmonary hypertension and the Eisenmenger syndrome and may offer the only realistic hope for palliation of advanced disease.
